新型冠状病毒肺炎合并急性呼吸窘迫综合征的研究进展
Recent research progress of acute respiratory distress syndrome in COVID-19 patients
摘要新型冠状病毒肺炎(COVID-19)给我国乃至世界带来巨大的公共卫生问题。目前尚无针对于COVID-19的特效药。急性呼吸窘迫综合征是COVID-19患者的常见致命性并发症之一,与其较高的重症率和病死率相关。本文结合相关文献、近期临床观察以及既往经验,对COVID-19合并急性呼吸窘迫综合征的关联进行解读,并对其治疗和管理进行探索性综述,以期为临床治疗提供参考。
更多相关知识
abstractsThe outbreak of COVID-19 has brought huge public health problems to China and even the world.Currently, there is no certain cure medication for COVID-19.Acute respiratory distress syndrome (ARDS) is one of the most common fatal complications of COVID-19, which is associated with the high risk of severity and mortality.Based on the relevant literature, recent clinical observations and experiences of ARDS in COVID-19, this article aim to discuss the clinical relevance between COVID-19 and ARDS, with the hope of improving the treatment and management of ARDS in COVID-19 patients.
More相关知识
- 浏览0
- 被引5
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



